Intron a and Diazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intron a (interferon alfa-2b) and Diazepam (diazepam). Common drug interactions include dyspnoea among females and pulmonary hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Intron a and Diazepam. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

What is Diazepam?

Diazepam has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 108,384 Diazepam users. Check the latest studies of Diazepam.



On Aug, 04, 2026

24 people who take Intron a and Diazepam together, and have interactions are studied.

Intron a and Diazepam drug interactions.

What are the common drug interactions of Intron A and Diazepam, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal distension
  3. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  4. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  5. Cerebral haemorrhage (bleeding within the brain)
  6. Chest pain
  7. Duodenal ulcer
  8. Dysuria (painful or difficult urination)
  9. Face oedema (swelling of face)
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

male:

  1. Pulmonary hypertension (increase in blood pressure in the lung artery)
  2. Restrictive cardiomyopathy (a condition in which the walls of the lower chambers of the heart (the ventricles) are abnormally rigid and lack the flexibility)
  3. Non-small cell lung cancer (type of epithelial lung cancer)
  4. Pancreatitis acute (sudden inflammation of pancreas)
  5. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  6. White blood cell count decreased
  7. Chills (felling of cold)
  8. Dizziness
  9. Haemorrhage intracranial (bleeding within the skull)
  10. Myositis (inflammation of the muscles)

What are the common drug interactions of Intron A and Diazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Pulmonary hypertension (increase in blood pressure in the lung artery)
  2. Restrictive cardiomyopathy (a condition in which the walls of the lower chambers of the heart (the ventricles) are abnormally rigid and lack the flexibility)
  3. Heart transplant

10-19:

n/a

20-29:

n/a

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal distension
  3. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  4. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  5. Chest pain
  6. Duodenal ulcer
  7. Dysuria (painful or difficult urination)
  8. Face oedema (swelling of face)
  9. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  10. Pulmonary congestion (congestion in the lungs)

40-49:

  1. Confusion
  2. Coordination abnormal (abnormal movement)
  3. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  4. Depression
  5. Difficulty in walking
  6. Disturbance in attention
  7. Drug effect decreased
  8. Dysarthria (speech disorder)
  9. Gait festinating
  10. Galactorrhoea (secretion of breast milk in men)

50-59:

  1. Pleural infection (infection of membrane of lungs)

60+:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Pancreatitis acute (sudden inflammation of pancreas)
  3. Abasia (inability to walk)
  4. Dizziness
  5. Dysstasia (difficulty in standing)
  6. Myositis (inflammation of the muscles)
  7. Nuclear magnetic resonance imaging brain
  8. Retinopathy (acute damage to the retina of the eye)
  9. Vertigo

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 41.67%
  2. Hepatitis C: 3 people, 12.50%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 8.33%
  4. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Intron a and Diazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Intron a and Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Intron a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intron a and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on interferon alfa-2b and diazepam (the active ingredients of Intron a and Diazepam, respectively), and Intron a and Diazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: